Event Info


Optimising patient management in Stage III Unresectable NSCLC

  • Date: 16/09/2020 Time: 7:30 PM (Australian Eastern Standard Time: UTC+10)
By continuing to use this website, you consent to the terms of Webstream Communication's Privacy Policy
This webcast has been initiated, organised and funded by AstraZeneca. The content is intended for registered HealthCare Professionals for educational purposes. Attendance at AstraZeneca educational meetings is by invitation only and limited to registered healthcare professionals. The company seeks no commitment from external stakeholders to take any action as a result of the invitation or related support.

PRIVACY STATEMENT: Your personal information (“Information”) will be collected and used by AstraZeneca Pty Ltd (“AstraZeneca”) for the purpose of administration of the webcast , for follow-up purposes and for any other purpose described in AstraZeneca’s Privacy Policy (see below for link). AstraZeneca may disclose your Information to third parties such as our related entities or service providers (including IT support/service providers), some of which may be located overseas including in the US, European Union and Asia Pacific. Please refer to our Privacy Policy at for more information about how your Information is handled and how you may seek to access or correct your Information, or submit a privacy complaint. AstraZeneca’s address is 66 Talavera Road, Macquarie Park, NSW, 2113. Registered user AstraZeneca Pty. Ltd. ABN 54 009 682 311. 66 Talavera Road, Macquarie Park, NSW 2113. www.astrazeneca.com.au. For Medical Information enquiries: 1800 805 342 or medinfo.australia@astrazeneca.com. To report an adverse event: 1800 805 342 or via , https://aereporting.astrazeneca.com .